medroxyprogesterone acetate has been researched along with 46, XY Gonadal Dysgenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botsis, D; Creatsas, G; Deligeoroglou, E; Makrakis, E; Papagianni, V | 1 |
1 other study(ies) available for medroxyprogesterone acetate and 46, XY Gonadal Dysgenesis
Article | Year |
---|---|
Response to hormonal treatment of young females with primary or very premature ovarian failure.
Topics: Adolescent; Amenorrhea; Bone Density; Cholesterol, HDL; Estrogens; Estrogens, Conjugated (USP); Female; Gonadal Dysgenesis, 46,XY; Humans; Medroxyprogesterone Acetate; Primary Ovarian Insufficiency; Turner Syndrome; Young Adult | 2011 |